nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitroglycerin—Dermatitis contact—Betamethasone—ankylosing spondylitis	0.00716	0.00716	CcSEcCtD
Nitroglycerin—Visual disturbance—Prednisolone—ankylosing spondylitis	0.00665	0.00665	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.00651	0.00651	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.00599	0.00599	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00597	0.00597	CcSEcCtD
Nitroglycerin—Visual disturbance—Dexamethasone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Nitroglycerin—Visual disturbance—Betamethasone—ankylosing spondylitis	0.00555	0.00555	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Nitroglycerin—Sweating increased—Prednisolone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Nitroglycerin—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Nitroglycerin—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Nitroglycerin—Coma—Methotrexate—ankylosing spondylitis	0.00482	0.00482	CcSEcCtD
Nitroglycerin—Infestation—Methylprednisolone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Nitroglycerin—Infestation NOS—Methylprednisolone—ankylosing spondylitis	0.00446	0.00446	CcSEcCtD
Nitroglycerin—Bradycardia—Prednisolone—ankylosing spondylitis	0.00444	0.00444	CcSEcCtD
Nitroglycerin—Sweating increased—Betamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Nitroglycerin—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Nitroglycerin—Sweating—Methylprednisolone—ankylosing spondylitis	0.00427	0.00427	CcSEcCtD
Nitroglycerin—Visual impairment—Prednisolone—ankylosing spondylitis	0.0042	0.0042	CcSEcCtD
Nitroglycerin—Renal failure acute—Methotrexate—ankylosing spondylitis	0.00414	0.00414	CcSEcCtD
Nitroglycerin—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00408	0.00408	CcSEcCtD
Nitroglycerin—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00407	0.00407	CcSEcCtD
Nitroglycerin—Dermatitis exfoliative—Methotrexate—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Nitroglycerin—Visual disturbance—Methotrexate—ankylosing spondylitis	0.00404	0.00404	CcSEcCtD
Nitroglycerin—Rhinitis—Triamcinolone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Nitroglycerin—Rhinitis—Methylprednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Nitroglycerin—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00398	0.00398	CcSEcCtD
Nitroglycerin—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00395	0.00395	CcSEcCtD
Nitroglycerin—Arrhythmia—Prednisolone—ankylosing spondylitis	0.00389	0.00389	CcSEcCtD
Nitroglycerin—Sweating increased—Prednisone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Nitroglycerin—Visual impairment—Methylprednisolone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Nitroglycerin—Erythema—Prednisolone—ankylosing spondylitis	0.00379	0.00379	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00371	0.00371	CcSEcCtD
Nitroglycerin—Bradycardia—Dexamethasone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Nitroglycerin—Bradycardia—Betamethasone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Nitroglycerin—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00363	0.00363	CcSEcCtD
Nitroglycerin—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00361	0.00361	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.0036	0.0036	CcSEcCtD
Nitroglycerin—Arrhythmia—Triamcinolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Nitroglycerin—Vision blurred—Prednisolone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Nitroglycerin—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Nitroglycerin—Visual impairment—Betamethasone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Nitroglycerin—Visual impairment—Dexamethasone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Nitroglycerin—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.0035	0.0035	CcSEcCtD
Nitroglycerin—Erythema—Triamcinolone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Nitroglycerin—Erythema—Methylprednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Nitroglycerin—Angioedema—Prednisolone—ankylosing spondylitis	0.00347	0.00347	CcSEcCtD
Nitroglycerin—Vertigo—Prednisolone—ankylosing spondylitis	0.00341	0.00341	CcSEcCtD
Nitroglycerin—Syncope—Prednisolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Nitroglycerin—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Nitroglycerin—Angiopathy—Betamethasone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Nitroglycerin—Angiopathy—Dexamethasone—ankylosing spondylitis	0.0033	0.0033	CcSEcCtD
Nitroglycerin—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Nitroglycerin—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00325	0.00325	CcSEcCtD
Nitroglycerin—Bradycardia—Prednisone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Nitroglycerin—Angioedema—Triamcinolone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Nitroglycerin—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Nitroglycerin—Erythema—Betamethasone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Nitroglycerin—Erythema—Dexamethasone—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Nitroglycerin—Vertigo—Triamcinolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nitroglycerin—Syncope—Triamcinolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nitroglycerin—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00313	0.00313	CcSEcCtD
Nitroglycerin—Syncope—Methylprednisolone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Nitroglycerin—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Nitroglycerin—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Nitroglycerin—Shock—Prednisolone—ankylosing spondylitis	0.00305	0.00305	CcSEcCtD
Nitroglycerin—Tachycardia—Prednisolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00299	0.00299	CcSEcCtD
Nitroglycerin—Drowsiness—Methotrexate—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Nitroglycerin—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Nitroglycerin—Infestation—Methotrexate—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Nitroglycerin—Flushing—Prednisone—ankylosing spondylitis	0.00294	0.00294	CcSEcCtD
Nitroglycerin—Angioedema—Dexamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Nitroglycerin—Angioedema—Betamethasone—ankylosing spondylitis	0.00289	0.00289	CcSEcCtD
Nitroglycerin—Stomatitis—Methotrexate—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Nitroglycerin—Angiopathy—Prednisone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Nitroglycerin—Confusional state—Methylprednisolone—ankylosing spondylitis	0.00287	0.00287	CcSEcCtD
Nitroglycerin—Immune system disorder—Prednisone—ankylosing spondylitis	0.00286	0.00286	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00285	0.00285	CcSEcCtD
Nitroglycerin—Vertigo—Betamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nitroglycerin—Vertigo—Dexamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nitroglycerin—Syncope—Betamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nitroglycerin—Syncope—Dexamethasone—ankylosing spondylitis	0.00284	0.00284	CcSEcCtD
Nitroglycerin—Arrhythmia—Prednisone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Nitroglycerin—Infection—Triamcinolone—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Nitroglycerin—Sweating—Methotrexate—ankylosing spondylitis	0.00283	0.00283	CcSEcCtD
Nitroglycerin—Infection—Methylprednisolone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Nitroglycerin—Shock—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Nitroglycerin—Shock—Methylprednisolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Nitroglycerin—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nitroglycerin—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nitroglycerin—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nitroglycerin—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00278	0.00278	CcSEcCtD
Nitroglycerin—Mental disorder—Prednisone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Nitroglycerin—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00277	0.00277	CcSEcCtD
Nitroglycerin—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nitroglycerin—Erythema—Prednisone—ankylosing spondylitis	0.00276	0.00276	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Nitroglycerin—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Nitroglycerin—Pharyngitis—Methotrexate—ankylosing spondylitis	0.00263	0.00263	CcSEcCtD
Nitroglycerin—Vision blurred—Prednisone—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00258	0.00258	CcSEcCtD
Nitroglycerin—Infection—Dexamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Nitroglycerin—Infection—Betamethasone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Nitroglycerin—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Nitroglycerin—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Nitroglycerin—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Nitroglycerin—Visual impairment—Methotrexate—ankylosing spondylitis	0.00255	0.00255	CcSEcCtD
Nitroglycerin—Shock—Dexamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Nitroglycerin—Shock—Betamethasone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Nitroglycerin—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.00254	0.00254	CcSEcCtD
Nitroglycerin—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Nitroglycerin—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Nitroglycerin—Agitation—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Nitroglycerin—Tachycardia—Betamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nitroglycerin—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nitroglycerin—Angioedema—Prednisone—ankylosing spondylitis	0.00252	0.00252	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.0025	0.0025	CcSEcCtD
Nitroglycerin—Vertigo—Prednisone—ankylosing spondylitis	0.00248	0.00248	CcSEcCtD
Nitroglycerin—Syncope—Prednisone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Nitroglycerin—Urticaria—Prednisolone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Nitroglycerin—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Nitroglycerin—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Nitroglycerin—Hypotension—Dexamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Nitroglycerin—Hypotension—Betamethasone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Nitroglycerin—Angiopathy—Methotrexate—ankylosing spondylitis	0.0024	0.0024	CcSEcCtD
Nitroglycerin—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Nitroglycerin—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Nitroglycerin—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00234	0.00234	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00233	0.00233	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nitroglycerin—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nitroglycerin—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nitroglycerin—Mental disorder—Methotrexate—ankylosing spondylitis	0.00232	0.00232	CcSEcCtD
Nitroglycerin—Erythema—Methotrexate—ankylosing spondylitis	0.0023	0.0023	CcSEcCtD
Nitroglycerin—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Nitroglycerin—Urticaria—Triamcinolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Nitroglycerin—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Nitroglycerin—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Nitroglycerin—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Nitroglycerin—Infection—Prednisone—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Nitroglycerin—Shock—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Nitroglycerin—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Nitroglycerin—Tachycardia—Prednisone—ankylosing spondylitis	0.0022	0.0022	CcSEcCtD
Nitroglycerin—Skin disorder—Prednisone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.00218	0.00218	CcSEcCtD
Nitroglycerin—Vision blurred—Methotrexate—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Nitroglycerin—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Nitroglycerin—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00213	0.00213	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00211	0.00211	CcSEcCtD
Nitroglycerin—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0021	0.0021	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00209	0.00209	CcSEcCtD
Nitroglycerin—Vertigo—Methotrexate—ankylosing spondylitis	0.00207	0.00207	CcSEcCtD
Nitroglycerin—Urticaria—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Nitroglycerin—Urticaria—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Nitroglycerin—Dizziness—Prednisolone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Nitroglycerin—Asthenia—Triamcinolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Nitroglycerin—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Nitroglycerin—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Nitroglycerin—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Nitroglycerin—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Nitroglycerin—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00204	0.00204	CcSEcCtD
Nitroglycerin—Paraesthesia—Prednisone—ankylosing spondylitis	0.00202	0.00202	CcSEcCtD
Nitroglycerin—Pruritus—Triamcinolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Nitroglycerin—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00201	0.00201	CcSEcCtD
Nitroglycerin—Rash—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Nitroglycerin—Dermatitis—Prednisolone—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Nitroglycerin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00195	0.00195	CcSEcCtD
Nitroglycerin—Headache—Prednisolone—ankylosing spondylitis	0.00194	0.00194	CcSEcCtD
Nitroglycerin—Confusional state—Methotrexate—ankylosing spondylitis	0.0019	0.0019	CcSEcCtD
Nitroglycerin—Dizziness—Triamcinolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Nitroglycerin—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Nitroglycerin—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Nitroglycerin—Infection—Methotrexate—ankylosing spondylitis	0.00187	0.00187	CcSEcCtD
Nitroglycerin—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Nitroglycerin—Asthenia—Dexamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Nitroglycerin—Asthenia—Betamethasone—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Nitroglycerin—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Nitroglycerin—Nausea—Prednisolone—ankylosing spondylitis	0.00184	0.00184	CcSEcCtD
Nitroglycerin—Pruritus—Dexamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Nitroglycerin—Pruritus—Betamethasone—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Nitroglycerin—Skin disorder—Methotrexate—ankylosing spondylitis	0.00183	0.00183	CcSEcCtD
Nitroglycerin—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00182	0.00182	CcSEcCtD
Nitroglycerin—Vomiting—Triamcinolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Nitroglycerin—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00181	0.00181	CcSEcCtD
Nitroglycerin—Rash—Triamcinolone—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Nitroglycerin—Dermatitis—Triamcinolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nitroglycerin—Rash—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nitroglycerin—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nitroglycerin—Urticaria—Prednisone—ankylosing spondylitis	0.00179	0.00179	CcSEcCtD
Nitroglycerin—Headache—Triamcinolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nitroglycerin—Headache—Methylprednisolone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nitroglycerin—Abdominal pain—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nitroglycerin—Body temperature increased—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Nitroglycerin—Hypotension—Methotrexate—ankylosing spondylitis	0.00176	0.00176	CcSEcCtD
Nitroglycerin—Dizziness—Dexamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Nitroglycerin—Dizziness—Betamethasone—ankylosing spondylitis	0.00171	0.00171	CcSEcCtD
Nitroglycerin—Nausea—Triamcinolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Paraesthesia—Methotrexate—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Nausea—Methylprednisolone—ankylosing spondylitis	0.00169	0.00169	CcSEcCtD
Nitroglycerin—Dyspnoea—Methotrexate—ankylosing spondylitis	0.00168	0.00168	CcSEcCtD
Nitroglycerin—Somnolence—Methotrexate—ankylosing spondylitis	0.00167	0.00167	CcSEcCtD
Nitroglycerin—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Nitroglycerin—Vomiting—Dexamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Nitroglycerin—Vomiting—Betamethasone—ankylosing spondylitis	0.00164	0.00164	CcSEcCtD
Nitroglycerin—Rash—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Rash—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Dermatitis—Betamethasone—ankylosing spondylitis	0.00163	0.00163	CcSEcCtD
Nitroglycerin—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Nitroglycerin—Headache—Dexamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Nitroglycerin—Headache—Betamethasone—ankylosing spondylitis	0.00162	0.00162	CcSEcCtD
Nitroglycerin—Asthenia—Prednisone—ankylosing spondylitis	0.00161	0.00161	CcSEcCtD
Nitroglycerin—Pruritus—Prednisone—ankylosing spondylitis	0.00159	0.00159	CcSEcCtD
Nitroglycerin—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.00155	0.00155	CcSEcCtD
Nitroglycerin—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00154	0.00154	CcSEcCtD
Nitroglycerin—Nausea—Betamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Nitroglycerin—Nausea—Dexamethasone—ankylosing spondylitis	0.00153	0.00153	CcSEcCtD
Nitroglycerin—Urticaria—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Dizziness—Prednisone—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
Nitroglycerin—Vomiting—Prednisone—ankylosing spondylitis	0.00143	0.00143	CcSEcCtD
Nitroglycerin—Rash—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Nitroglycerin—Dermatitis—Prednisone—ankylosing spondylitis	0.00142	0.00142	CcSEcCtD
Nitroglycerin—Headache—Prednisone—ankylosing spondylitis	0.00141	0.00141	CcSEcCtD
Nitroglycerin—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00139	0.00139	CcSEcCtD
Nitroglycerin—Asthenia—Methotrexate—ankylosing spondylitis	0.00135	0.00135	CcSEcCtD
Nitroglycerin—Nausea—Prednisone—ankylosing spondylitis	0.00134	0.00134	CcSEcCtD
Nitroglycerin—Pruritus—Methotrexate—ankylosing spondylitis	0.00133	0.00133	CcSEcCtD
Nitroglycerin—Dizziness—Methotrexate—ankylosing spondylitis	0.00124	0.00124	CcSEcCtD
Nitroglycerin—Vomiting—Methotrexate—ankylosing spondylitis	0.0012	0.0012	CcSEcCtD
Nitroglycerin—Rash—Methotrexate—ankylosing spondylitis	0.00119	0.00119	CcSEcCtD
Nitroglycerin—Dermatitis—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Nitroglycerin—Headache—Methotrexate—ankylosing spondylitis	0.00118	0.00118	CcSEcCtD
Nitroglycerin—Nausea—Methotrexate—ankylosing spondylitis	0.00112	0.00112	CcSEcCtD
